Industry: Pharmaceuticals, Biotechnology
Magen BioSciences is a specialty pharmaceutical company focused on developing proprietary medical therapies for the dermatology market. Magen was co-founded in March 2006 by Richard Aldrich, David Fisher, M.D. Ph.D., Phillip Sharp, Ph.D., David Shaw, Christopher Walsh, Ph.D. and Christoph Westphal, M.D., Ph.D. Investors include Alexandria Real Estate, ARCH Venture Partners, Highland Capital Partners, IDG Ventures, Lux Capital, QVT Financial LP, TVM Capital and Venrock Associates. ( www.magenbiosciences.com )
Magen BioSciences , Inc.
790 Memorial Drive Suite 200B
Cambridge, Massachusetts 02139
USA
Tel: (617) 494-8732
Fax: (617) 494-8752